Plain-English translation of NCT06591039 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Neoplasms research guide →This is a large observational study that aims to gather information from the medical records of 20,000 patients with breast cancer across hospitals in China. The research team will collect data about how breast cancer is currently being diagnosed and treated, then use that information to identify patterns, evaluate the quality of care, and propose improvements to treatment standards.
Currently, there is no comprehensive picture of how breast cancer care is being delivered across China's hospitals. This study exists to fill that gap by gathering real-world information about diagnosis and treatment practices, which will help doctors and health officials understand what's working well and where improvements can be made.
Your participation involves allowing the research team to access and review your medical records — information that is already part of your hospital care. You will not need to take any new medication or undergo additional procedures. The study team will collect data about your diagnosis, treatment, and outcomes over time as part of a long-term registry to track how breast cancer care evolves.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
China
Sponsor
Fudan University
Enrollment target
~20,000 participants
Started
July 2022
Primary completion
July 2025
Last updated on clinicaltrials.gov in September 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jiong Wu, M.D
Cancer Hospital/ Institute, Fudan University